Propanc Biopharma, Inc. Common Stock Financial Flexibility Index
Propanc Biopharma, Inc. Common Stock financial flexibility index. Propanc Biopharma, Inc. Common Stock (PPCB) has a Financial Flexibility Index of -0.50x as of June 2026. Free cash flow of $-1.70 Million (operating CF $-1.70 Million minus capex $51.00) represents -1% of total liabilities ($3.38 Million). See how much free cash does Propanc Biopharma, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Propanc Biopharma, Inc. Common Stock (2010–2026)
Financial flexibility index of Propanc Biopharma, Inc. Common Stock from 2010 to 2026. Historical Financial Flexibility Index trend for Propanc Biopharma, Inc. Common Stock across 17 annual periods. Check PPCB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Propanc Biopharma, Inc. Common Stock Financial Flexibility Index by Year (2010–2026)
Propanc Biopharma, Inc. Common Stock financial flexibility index by year from 2010 to 2026. Year-by-year free cash flow to debt coverage for Propanc Biopharma, Inc. Common Stock. For the full cash flow conversion analysis, see PPCB cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -1.68x | $-5.68 Million | $-5.68 Million | $3.38 Million | ▼ -2275.0% |
| 2025 | -0.07x | $-405.17K | $-405.17K | $5.73 Million | ▲ +70.9% |
| 2024 | -0.24x | $-935.12K | $-935.12K | $3.85 Million | ▲ +30.2% |
| 2023 | -0.35x | $-1.11 Million | $-1.11 Million | $3.18 Million | ▲ +24.8% |
| 2022 | -0.46x | $-1.44 Million | $-1.44 Million | $3.11 Million | ▼ -24.4% |
| 2021 | -0.37x | $-1.15 Million | $-1.15 Million | $3.08 Million | ▲ +24.8% |
| 2020 | -0.49x | $-1.85 Million | $-1.85 Million | $3.74 Million | ▼ -5.8% |
| 2019 | -0.47x | $-2.06 Million | $-2.06 Million | $4.40 Million | — |
| 2018 | 0.00x | $0.00 | $-2.18 Million | $6.82 Million | ▲ +100.0% |
| 2017 | -0.39x | $-2.15 Million | $-2.15 Million | $5.54 Million | ▲ +76.1% |
| 2016 | -1.63x | $-4.79 Million | $-4.80 Million | $2.94 Million | ▼ -320.9% |
| 2015 | -0.39x | $-1.42 Million | $-1.43 Million | $3.68 Million | ▼ -159.8% |
| 2014 | -0.15x | $-226.44K | $-226.44K | $1.52 Million | ▲ +8.2% |
| 2013 | -0.16x | $-128.64K | $-128.65K | $794.22K | ▲ +44.4% |
| 2012 | -0.29x | $-170.28K | $-170.28K | $584.19K | ▲ +93.6% |
| 2011 | -4.54x | $-1.39 Million | $-1.40 Million | $306.85K | ▼ -446.6% |
| 2010 | -0.83x | $-191.51K | $-191.51K | $230.76K | — |